risperidone

Key facts

INN

risperidone

Brand

RISPERIDONE

Route

INTRAMUSCULAR

Formulation

TABLET, ORALLY DISINTEGRATING

Originator

Amneal Pharmaceuticals

Related patents

patent

US 11712475

Sustained delivery formulations of risperidone compound

Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11013809

Sustained delivery formulations of risperidone compound

Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10376590

Sustained delivery formulations of risperidone compound

Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10010612

Sustained delivery formulations of risperidone compounds

Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9186413

Sustained delivery formulations of risperidone compounds

Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9180197

Sustained delivery formulations of risperidone compounds

Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9107832

Risperidone microparticles formed by sublimation

Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9050343

Combination of pimavanserin and risperidone for the treatment of psychosis

Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is risperidone?

risperidone (RISPERIDONE), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for risperidone?

RISPERIDONE is a marketed brand name for risperidone. Check FDA Drugs@FDA for the current US label holder.